These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3488554)

  • 21. Chronic ACTH treatment: influence on 5-HT2 receptors and behavioral supersensitivity induced by 5,7-dihydroxytryptamine lesions.
    Pranzatelli MR; Eng B
    Peptides; 1989; 10(1):5-8. PubMed ID: 2546129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased sensitivity to intracerebroventricular infusion of serotonin and deaminated indoles after lesioning rat with dihydroxytryptamine.
    Warbritton JD; Stewart RM; Baldessarini RJ
    Brain Res; 1980 Feb; 183(2):355-66. PubMed ID: 6153283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early postnatal administration of 5,7-DHT: effects on serotonergic neurons and terminals.
    Towle AC; Breese GR; Mueller RA; Coyle S; Lauder JM
    Brain Res; 1984 Sep; 310(1):67-75. PubMed ID: 6383521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of neonatal administration of 5,7-dihydroxytryptamine on locomotor activity.
    Lucot JB; Seiden LS
    Psychopharmacology (Berl); 1982; 77(2):114-6. PubMed ID: 6812128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The behavioral effects of depletions of brain serotonin induced by 5,7-dihydroxytryptamine vary with time after administration.
    Gately PF; Segal DS; Geyer MA
    Behav Neural Biol; 1986 Jan; 45(1):31-42. PubMed ID: 3954713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests.
    Eide PK; Hole K; Berge OG; Broch OJ
    Brain Res; 1988 Feb; 440(1):42-52. PubMed ID: 2965956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 5,7-dihydroxytryptamine injections in the fornix-fimbria on locomotor activity in photocell cages and the open field.
    Williams JH; Meara JR; Azmitia EC
    Behav Brain Res; 1990 Oct; 40(1):37-44. PubMed ID: 2278655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-raphe neurokinin-induced hyperactivity: effects of 5,7-dihydroxytryptamine lesions.
    Paris JM; Mitsushio H; Lorens SA
    Brain Res; 1989 Jan; 476(1):183-8. PubMed ID: 2464417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of 5,7-dihydroxytryptamine-induced supersensitivity to 5-hydroxytryptophan in mice by treatment with cycloheximide.
    Sperk G; Stewart RM; Campbell A; Baldessarini RJ
    Brain Res; 1978 Dec; 159(1):183-94. PubMed ID: 310331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioural modification of bulbospinal serotonergic inhibition and morphine analgesia.
    Milne RJ; Gamble GD
    Brain Res; 1990 Jun; 521(1-2):167-74. PubMed ID: 2207657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supersensitivity of 5,7-dihydroxytryptamine-treated rats to the respiratory depressant and antitussive effects of dihydrocodeine.
    Kamei J; Ogawa M; Kasuya Y
    Eur J Pharmacol; 1988 Aug; 153(2-3):305-8. PubMed ID: 3181291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of nicotine-induced hyperactivity by pCPA.
    Fitzgerald RE; Oettinger R; Bättig K
    Pharmacol Biochem Behav; 1985 Aug; 23(2):279-84. PubMed ID: 2932743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Selective lesions of serotonergic raphe neurons produced by 5,7-dihydroxytryptamine: effects on interspecific aggressive behavior in the rat].
    Vergnes M; Penot C; Kempf E; Mack G
    Brain Res; 1977 Sep; 133(1):167-71. PubMed ID: 561640
    [No Abstract]   [Full Text] [Related]  

  • 34. 5,7-Dihydroxytryptamine modifies excitability of rat dorsal raphe serotonergic neurons in vitro.
    Segal M
    Neurosci Lett; 1986 Nov; 71(3):306-10. PubMed ID: 3796886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of ECS-induced retrograde amnesia of passive avoidance conditioning after 5,7-dihydroxytryptamine median raphe nucleus lesion in the rat.
    Montanaro N; Dall'Olio R; Gandolfi O
    Neuropsychobiology; 1981; 7(2):57-66. PubMed ID: 6969865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine.
    Stachowiak MK; Stricker EM; Jacoby JH; Zigmond MJ
    Biochem Pharmacol; 1986 Apr; 35(8):1241-8. PubMed ID: 2421731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal effects of intrahypothalamic 5,7-dihydroxytryptamine: relationship between serotonin levels and [3H]serotonin binding.
    Frankfurt M; Allen DL; Luine VN; Beaudet A
    Brain Res; 1987 Sep; 419(1-2):216-22. PubMed ID: 2445421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Denervation supersensitivity to 5-hydroxytryptophan in rats following spinal transection and 5,7-dihydroxytryptamine injection.
    Barbeau H; Bédard P
    Neuropharmacology; 1981 Jun; 20(6):611-6. PubMed ID: 6972494
    [No Abstract]   [Full Text] [Related]  

  • 39. Differential effects of p-chlorophenylalanine and 5,7-dihydroxytryptamine on feeding in rats.
    Hoebel BG; Zemlan FP; Trulson ME; MacKenzie RG; DuCret RP; Norelli C
    Ann N Y Acad Sci; 1978 Jun; 305():590-4. PubMed ID: 152082
    [No Abstract]   [Full Text] [Related]  

  • 40. Biochemical evidence for alteration of neostriatal dopaminergic function by 5,7-dihydroxytryptamine.
    Liston DR; Franz DN; Gibb JW
    J Neurochem; 1982 May; 38(5):1329-35. PubMed ID: 6121011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.